Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Brain and Central Nervous System TumorsThromboembolism
Interventions
OTHER

laboratory biomarker analysis

OTHER

physiologic testing

PROCEDURE

management of therapy complications

Trial Locations (9)

30322

Winship Cancer Institute of Emory University, Atlanta

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48202

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit

33612-9497

H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114

Massachusetts General Hospital, Boston

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

North American Brain Tumor Consortium

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00253669 - Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas | Biotech Hunter | Biotech Hunter